Biologically Active Small Molecules, LKT Labs, 849217-68-1

HomeAll Products

849217-68-1 LKT Labs Biologically Active Small Molecules

1 - 1 of 1
Sort
View
Show
  • LKT Labs

    Cabozantanib is an anticancer chemotherapeutic compound that has been approved to treat medullary thyroid cancer and is in clinical trials as a treatment for other types of solid tumors. Cabozantanib exerts its anticancer activity through inhibition of Met, RET, and VEGFR2, increasing apoptosis and…